Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125715951 | 12571595 | 1 | I | 20160709 | 20160711 | 20160719 | 20160719 | PER | US-ELI_LILLY_AND_COMPANY-US201607004691 | ELI LILLY AND CO | 65.39 | YR | F | Y | 0.00000 | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125715951 | 12571595 | 1 | PS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 6 U, EACH MORNING | 20563 | 6 | IU | INJECTION | QD | ||||||
| 125715951 | 12571595 | 2 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 3 U, AT LUNCH | 20563 | 3 | IU | INJECTION | QD | ||||||
| 125715951 | 12571595 | 3 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 6 U, EACH EVENING | 20563 | 6 | IU | INJECTION | QD | ||||||
| 125715951 | 12571595 | 4 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 6 U, EACH MORNING | C536019D | 20563 | 6 | IU | INJECTION | QD | |||||
| 125715951 | 12571595 | 5 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 3 U, AT LUNCH | C536019D | 20563 | 3 | IU | INJECTION | QD | |||||
| 125715951 | 12571595 | 6 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 6 U, EACH EVENING | C536019D | 20563 | 6 | IU | INJECTION | QD | |||||
| 125715951 | 12571595 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | UNK, EACH EVENING | U | 0 | QD | |||||||||
| 125715951 | 12571595 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 9 | C | CALCIUM | CALCIUM | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 10 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 1 DF, QD | U | 0 | 1 | DF | QD | |||||||
| 125715951 | 12571595 | 11 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 12 | C | DILANTIN | PHENYTOIN | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 13 | C | FENOFIBRIC ACID. | FENOFIBRIC ACID | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 14 | C | GLUCAGON EMERGENCY KIT | GLUCAGON | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 15 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 16 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 17 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 18 | C | LEVOCETIRIZINE | LEVOCETIRIZINE | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 19 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 20 | C | NABUMETONE. | NABUMETONE | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 21 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 22 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 1 DF, QD | U | 0 | 1 | DF | QD | |||||||
| 125715951 | 12571595 | 23 | C | QUINAPRIL. | QUINAPRIL | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 24 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 25 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 26 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 27 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | U | 0 | |||||||||||
| 125715951 | 12571595 | 28 | C | VITAMINS WITH MINERALS | MINERALSVITAMINS | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125715951 | 12571595 | 1 | Type 2 diabetes mellitus |
| 125715951 | 12571595 | 26 | Seasonal allergy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125715951 | 12571595 | Arthralgia | |
| 125715951 | 12571595 | Injection site erythema | |
| 125715951 | 12571595 | Injection site haemorrhage | |
| 125715951 | 12571595 | Injection site pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125715951 | 12571595 | 1 | 201601 | 0 | ||
| 125715951 | 12571595 | 2 | 201601 | 0 | ||
| 125715951 | 12571595 | 3 | 201601 | 0 |